Viewing nowBastatin Tablet 10 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
IYON Pharm Co., Ltd.

MFDS item code 201306059 · Approved 2013.03.06 · Insurance code 658602770
Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular diseases. It reduces the risk of myocardial infarction and stroke in adults with multiple risk factors for coronary heart disease and in patients with type 2 diabetes. Additionally, for adults with existing coronary heart disease, it has been shown to decrease the risk of non-fatal and fatal myocardial infarction, stroke, revascularization procedures, hospitalizations due to congestive heart failure, and angina. For patients with hyperlipidemia, this medication is used to lower total cholesterol, LDL cholesterol, Apo-B, and triglyceride levels, and to raise HDL cholesterol levels. It is particularly effective in controlling cholesterol levels in patients with familial hypercholesterolemia or in pediatric patients when used alongside dietary management. This medication is used to reduce and improve the risks associated with cardiovascular diseases and hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. The drug may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose adjusted accordingly. Patients with homozygous familial hypercholesterolemia This drug is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this drug greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate for each patient according to the recommended treatment goals. Adjust the dose at intervals of 4 weeks or longer.
This medication may cause unusual symptoms in the muscles; therefore, in case of severe muscle pain or weakness, or a significant increase in creatine kinase levels, it should be stopped immediately and a doctor consulted. Patients with liver function issues or liver disease should exercise caution, as taking this medication may worsen liver function, and regular liver function tests are necessary. Women who are pregnant or may become pregnant, as well as breastfeeding women, should not take this medication and should use appropriate contraceptive methods during treatment. This medication may have increased or decreased blood concentration when taken with certain drugs; therefore, patients should inform their doctor or pharmacist if they are taking other medications. Elderly patients or those with impaired kidney function should be monitored closely when using this medication due to the increased risk of muscle-related adverse reactions. If symptoms such as muscle pain, fatigue, or fever occur during treatment, medical personnel should be informed immediately and necessary tests should be conducted. When storing this medication, keep it out of reach of children and store it in its original container to prevent misuse or deterioration of quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air or moisture ingress. It is also best kept at room temperature between 1°C and 30°C to maintain its effectiveness.
White round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
IYON Pharm Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.